EUVIMEDEUVIMED entdecken
LeitlinieOpen Access

Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure Hospitalization

Einleitung, Adhärenz und Persistenz zur leitliniengerechten medikamentösen Therapie nach Hospitalisierung wegen Herzinsuffizienz

Lily G Bessette, Jared W Magnani, Maria M Brooks, Bridget M Mayrer, Ella Hileman-Kaplan, Gail D Gallman, Sonja A Swanson, Timothy S Anderson

JAMA Internal Medicine · 01.09.2026 · 186 (9) · 1155

DOI: 10.1001/jamainternmed.2026.2908 ↗

Auf einen Blick

Nach Herzinsuffizienz-Hospitalisierung blieben viele neu verordnete leitliniengerechte Medikamente ungenutzt oder wurden nach 6 Monaten nicht fortgeführt. Besonders häufig betraf das β-Blocker und RAS-Inhibitoren.

Fragestellung

Wie entwickeln sich Verordnung, Einlösung, Adhärenz und Persistenz von leitliniengerechter medikamentöser Therapie nach einer Hospitalisierung wegen Herzinsuffizienz?

Methode

Kohortenstudie in einem regionalen US-Gesundheitssystem bei nach Hause entlassenen Patient:innen nach Herzinsuffizienz-Hospitalisierung; Auswertung elektronischer Gesundheitsakten mit Apothekenabgaben; Nachbeobachtung bis 6 Monate.

Ergebnisse

6111 Patient:innen; 51 % erhielten bei Entlassung mindestens 1 neues HF-Medikament. 54 % der 4873 neuen Entlassverordnungen wurden innerhalb von 7 Tagen eingelöst, 20 % verzögert. Nach 6 Monaten waren 42 % adhärent und 51 % persistent zu allen HF-Medikamenten.

Schlussfolgerung der Autor:innen

Die Autor:innen schlussfolgern, dass nach Herzinsuffizienz-Hospitalisierung die meisten neuen leitliniengerechten Verordnungen nicht eingelöst wurden und die meisten neu begonnenen Therapien nach 6 Monaten nicht fortbestanden.

Kernaussagen

  • 51 % erhielten bei Entlassung mindestens 1 neues HF-Medikament.
  • 54 % der neuen Verordnungen wurden binnen 7 Tagen eingelöst.
  • Nach 6 Monaten: 42 % adhärent, 51 % persistent zu allen HF-Medikamenten.

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Leitlinie in der Zeitschrift JAMA Internal Medicine, erschienen am 01.09.2026. Verfasst von Lily G Bessette und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Department of Epidemiology, University of Pittsburgh, Pennsylvania. Hauptthemen laut MEDLINE: Heart Failure, Guideline Adherence, Drug Monitoring. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.

Auf einen BlickAbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Efforts to improve heart failure (HF) outcomes have focused on prescribing guideline-directed medical therapy at hospital discharge. Whether new prescriptions translate to sustained medication use after HF hospitalization is largely unknown.

Objective

To characterize medication-use patterns following HF hospitalizations. Design, Setting, and Participants A cohort study of patients in a regional US health system discharged home after an HF hospitalization between July 1, 2017, and March 30, 2023. Data were analyzed from August 2024 to February 2026. Main Outcomes and Measures Medications of interest included β-blockers, renin-angiotensin system inhibitors (RASis), mineralocorticoid receptor antagonists (MRAs), and sodium-glucose co-transporter 2 inhibitors (SGLT2is). New prescriptions were identified by in-hospital administration or discharge medication orders. Using electronic health records linked to pharmacy dispensation records, medication initiation (prescription dispensation) and primary nonadherence (discharge prescriptions that were not filled) were assessed at 7 and 90 days postdischarge. Adherence (proportion of days covered ≥80%) and persistence (continuous days’ supply) were assessed over 6 months postdischarge.

Results

This cohort study included 6111 patients with HF hospitalizations (mean [SD] age, 69.9 [13.6] years; 37.3% female [2277]) of whom 51% of were prescribed at least 1 new HF medication at discharge. At admission, 58.1% of patients were prescribed β-blockers (3549), 41.4% RASis (2530), 16.3% MRAs (997), and 4.9% SGLT2is (299); and at discharge, use increased to 73.3% (4481), 52.9% (3232), 28.5% (1740), and 9.0% (548), respectively. Primary nonadherence was observed in 51% (972 of 1904) of new prescriptions for β-blockers, 48% (659 of 1361) for RASis, 39% (482 of 1225) for MRAs, and 35% (134 of 383) for SGLT2is. Thus, of 4873 new discharge prescriptions, only 54% (2626) were initiated within 7 days of discharge and an additional 20% (954) had delayed initiation, between 7 and 90 days postdischarge. At 6 months, persistence to β-blockers was 70% (3127 of 4481), for RASis was 60% (1952 of 3232), for MRAs was 55% (961 of 1740), and for SGLT2is was 56% (306 of 548). As a result, at 6 months, only 42% (2188 of 5183) of patients were adherent and 51% (2620 of 5183) were persistent to all HF medications used at discharge. Conclusions and Relevance This cohort study found that following HF hospitalization, most new guideline-directed medical therapy prescriptions went unfilled. Moreover, most newly initiated prescriptions did not persist at 6 months, suggesting a need to develop interventions to support patients’ medication use beyond the initial prescription at discharge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureGuideline AdherenceDrug MonitoringHumansFemaleMaleAgedHospitalizationAdrenergic beta-AntagonistsCohort StudiesPatient DischargeMineralocorticoid Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsMiddle AgedSodium-Glucose Transporter 2 InhibitorsPractice Guidelines as TopicAged, 80 and over

Substanzen

Adrenergic beta-AntagonistsMineralocorticoid Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsSodium-Glucose Transporter 2 Inhibitors

Autor:innen und Institutionen

  • Department of Epidemiology, School of Public Health, Department of Epidemiology, University of Pittsburgh, Pennsylvania.
  • Department of Cardiology, University of Pittsburgh, Pennsylvania.
  • Division of Gastroenterology, Department of Medicine, University of Pittsburgh, Pennsylvania.
  • Division of General Internal Medicine, Department of Medicine, University of Pittsburgh, Pennsylvania.
  • Center for Pharmaceutical Policy and Prescribing, School of Medicine, University of Pittsburgh, Pennsylvania.
  • Center for Healthcare Evaluation Research and Promotion, Veterans Affairs (VA) Pittsburgh Healthcare System, Pennsylvania.

Förderung

  • NIA NIH HHS
  • NIGMS NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Bessette, L. G., Magnani, J. W., Brooks, M. M., Mayrer, B. M., Hileman-Kaplan, E., Gallman, G. D., Swanson, S. A., & Anderson, T. S. (2026). Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure Hospitalization. JAMA Internal Medicine, 186(9), 1155. https://doi.org/10.1001/jamainternmed.2026.2908

Vancouver

Bessette LG, Magnani JW, Brooks MM, Mayrer BM, Hileman-Kaplan E, Gallman GD, et al. Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure Hospitalization. JAMA Internal Medicine. 2026;186(9):1155. doi:10.1001/jamainternmed.2026.2908

BibTeX
@article{Bessette2026,
  author = {Bessette, Lily G and Magnani, Jared W and Brooks, Maria M and Mayrer, Bridget M and Hileman-Kaplan, Ella and Gallman, Gail D and Swanson, Sonja A and Anderson, Timothy S},
  title = {Initiation, Adherence, and Persistence to Guideline-Directed Medical Therapy After Heart Failure Hospitalization},
  journal = {JAMA Internal Medicine},
  year = {2026},
  volume = {186},
  number = {9},
  pages = {1155},
  doi = {10.1001/jamainternmed.2026.2908}
}
Kostenlos starten →